|
Volumn 20, Issue 16, 2010, Pages 4885-4891
|
Enhanced selectivity profile of pyrazole-urea based DFG-out p38α inhibitors
|
Author keywords
DFG out; Kinase inhibitor; p38; Pyrazole urea
|
Indexed keywords
DORAMAPIMOD;
IMATINIB;
MITOGEN ACTIVATED PROTEIN KINASE 14;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SORAFENIB;
UREA DERIVATIVE;
ADENINE;
CARBANILAMIDE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
ARTICLE;
DRUG DESIGN;
DRUG PROTEIN BINDING;
DRUG SELECTIVITY;
DRUG SPECIFICITY;
DRUG SYNTHESIS;
DRUG TARGETING;
HUMAN;
AMINO ACID SEQUENCE;
ANTAGONISTS AND INHIBITORS;
BINDING SITE;
CHEMISTRY;
METABOLISM;
MICROSOME;
PROTEIN MOTIF;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ADENINE;
AMINO ACID MOTIFS;
AMINO ACID SEQUENCE;
BINDING SITES;
HUMANS;
MICROSOMES;
MITOGEN-ACTIVATED PROTEIN KINASE 14;
PHENYLUREA COMPOUNDS;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 77955428704
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.06.073 Document Type: Article |
Times cited : (12)
|
References (24)
|